PaxMedica, Inc. Common Stock
General ticker "PXMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $116.2K (TTM average)
PaxMedica, Inc. Common Stock does not follow the US Stock Market performance with the rate: -9.3%.
Estimated limits based on current volatility of 84.6%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 7 (+133.3%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Operational and conduct risks, Clinical trial delays, Product liability, Market competition, Foreign operations risks
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.23$, 1.25$]
- 2024-12-30 to 2025-12-30 estimated range: [0.14$, 0.66$]
Short-term PXMD quotes
Long-term PXMD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $7.20MM | $10.60MM | $16.15MM |
| Operating Income | $-7.20MM | $-10.60MM | $-16.15MM |
| Non-Operating Income | $-3.03MM | $-4.20MM | $-2.14MM |
| Interest Expense | $2.81MM | $0.01MM | $0.01MM |
| R&D Expense | $2.23MM | $1.79MM | $3.91MM |
| Income(Loss) | $-10.23MM | $-14.80MM | $-18.29MM |
| Taxes | $2.81MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-15.84MM | $-14.80MM | $-18.29MM |
| Stockholders Equity | $-10.11MM | $0.11MM | $3.39MM |
| Assets | $0.65MM | $2.20MM | $5.68MM |
| Operating Cash Flow | $-5.51MM | $-6.07MM | $-10.77MM |
| Financing Cash Flow | $4.83MM | $7.53MM | $13.58MM |
| Earnings Per Share** | $-22.86 | $-28.79 | $-11.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.